128 related articles for article (PubMed ID: 2895830)
1. Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.
Weinhold KJ; Lyerly HK; Matthews TJ; Tyler DS; Ahearne PM; Stine KC; Langlois AJ; Durack DT; Bolognesi DP
Lancet; 1988 Apr; 1(8591):902-5. PubMed ID: 2895830
[TBL] [Abstract][Full Text] [Related]
2. GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
Tyler DS; Nastala CL; Stanley SD; Matthews TJ; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1989 Feb; 142(4):1177-82. PubMed ID: 2536767
[TBL] [Abstract][Full Text] [Related]
3. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
[TBL] [Abstract][Full Text] [Related]
4. Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera.
Koup RA; Sullivan JL; Levine PH; Brewster F; Mahr A; Mazzara G; McKenzie S; Panicali D
J Virol; 1989 Feb; 63(2):584-90. PubMed ID: 2536094
[TBL] [Abstract][Full Text] [Related]
5. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ
AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917
[TBL] [Abstract][Full Text] [Related]
6. Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.
Lyerly HK; Matthews TJ; Langlois AJ; Bolognesi DP; Weinhold KJ
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4601-5. PubMed ID: 3037522
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.
Evans LA; Thomson-Honnebier G; Steimer K; Paoletti E; Perkus ME; Hollander H; Levy JA
AIDS; 1989 May; 3(5):273-6. PubMed ID: 2548535
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.
Riviere Y; Tanneau-Salvadori F; Regnault A; Lopez O; Sansonetti P; Guy B; Kieny MP; Fournel JJ; Montagnier L
J Virol; 1989 May; 63(5):2270-7. PubMed ID: 2522999
[TBL] [Abstract][Full Text] [Related]
9. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
Tomescu C; Tebas P; Montaner LJ
AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
[TBL] [Abstract][Full Text] [Related]
10. Cellular immune response to viral peptides in patients exposed to HIV.
Ahearne PM; Matthews TJ; Lyerly HK; White GC; Bolognesi DP; Weinhold KJ
AIDS Res Hum Retroviruses; 1988 Aug; 4(4):259-67. PubMed ID: 2462895
[TBL] [Abstract][Full Text] [Related]
11. T cell recognition of HIV synthetic peptides in a natural infection.
Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.
Tyler DS; Stanley SD; Bartlett JA; Bolognesi DP; Weinhold KJ
J Surg Res; 1998 Oct; 79(2):115-20. PubMed ID: 9758725
[TBL] [Abstract][Full Text] [Related]
13. Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120.
Thiriart C; Francotte M; Cohen J; Collignon C; Delers A; Kummert S; Molitor C; Gilles D; Roelants P; van Wijnendaele F
J Immunol; 1989 Sep; 143(6):1832-6. PubMed ID: 2476484
[TBL] [Abstract][Full Text] [Related]
14. Certain human Gp120-HIV antibodies react with anti-CD4 antibodies.
Lundin K; Karlsson A; Nygren A; Löfström A; Gigliotti D; Wigzell H
Scand J Immunol; 1988 Jan; 27(1):113-7. PubMed ID: 2829345
[TBL] [Abstract][Full Text] [Related]
15. Role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases.
Brenner BG; Gryllis C; Wainberg MA
J Leukoc Biol; 1991 Dec; 50(6):628-40. PubMed ID: 1940615
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.
Krowka JF; Stites DP; Jain S; Steimer KS; George-Nascimento C; Gyenes A; Barr PJ; Hollander H; Moss AR; Homsy JM
J Clin Invest; 1989 Apr; 83(4):1198-203. PubMed ID: 2703528
[TBL] [Abstract][Full Text] [Related]
17. Isolate- and group-specific immune responses to the envelope protein of human immunodeficiency virus induced by a live recombinant vaccinia virus in macaques.
Earl PL; Robert-Guroff M; Matthews TJ; Krohn K; London WT; Moss B
AIDS Res Hum Retroviruses; 1989 Feb; 5(1):23-32. PubMed ID: 2541747
[TBL] [Abstract][Full Text] [Related]
18. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation.
Mittler RS; Hoffmann MK
Science; 1989 Sep; 245(4924):1380-2. PubMed ID: 2571187
[TBL] [Abstract][Full Text] [Related]
19. Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection.
Shafferman A; Lennox J; Grosfeld H; Sadoff J; Redfield RR; Burke DS
AIDS Res Hum Retroviruses; 1989 Feb; 5(1):33-9. PubMed ID: 2541748
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells.
Ojo-Amaize EA; Nishanian P; Keith DE; Houghton RL; Heitjan DF; Fahey JL; Giorgi JV
J Immunol; 1987 Oct; 139(7):2458-63. PubMed ID: 2821115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
